Jen Norton, vice president and head of US Value & Access, Amgen, discusses challenges related to cardiovascular disease (CVD) management and how stakeholders across the health care industry can partner to close gaps in care and reduce costs.
Jen Norton, vice president and head of US Value & Access, Amgen, discusses challenges related to cardiovascular disease (CVD) management and how stakeholders across the health care industry can partner to close gaps in care and reduce costs.
